Rabinowits, G., Homsi, J. , Park, S., Khushalani, N. , Panella, T. , Ellison, D., Gentry, R., Venna, S., Strasswimmer, J., Zuniga, R. , Chandra, S. , Ruiz, E., Migden, M., Ibrahim, S., Mehta, N. , Inocencio, T. , He, X., Zhang, H., Gillis, K. and Pouliot, J.-F. 2023. CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s174. DOI:https://doi.org/10.25251/skin.7.supp.174.